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The two domains of human galectin-8 bind
sialyl- and fucose-containing oligosaccharides
in an independent manner. A 3D view by
using NMR†
Marcos Gómez-Redondo,a Sandra Delgado,a Reyes Núñez-Franco,a
Gonzalo Jiménez-Osés, ab Ana Ardá,*ab Jesús Jiménez-Barbero *abc and
Ana Gimeno*a
The interaction of human galectin-8 and its two separate N-terminal and C-terminal carbohydrate
recognition domains (CRD) to their natural ligands has been analysed using a synergistic combination
of experimental NMR and ITC methods, and molecular dynamics simulations. Both domains bind
the minimal epitopes N-acetyllactosamine (1) and Galb1–3GalNAc (2) in a similar manner. However, the
N-terminal and C-terminal domains show exquisite and opposing specificity to bind either Neu5Ac- or
Fuc-containing ligands, respectively. Moreover, the addition of the high-affinity ligands specific for one
of the CRDs does not make any effect on the binding at the alternative one. Thus, the two CRDs behave
independently and may simultaneously target different molecular entities to promote clustering through
the generation of supramolecular assemblies.
Introduction
Galectins are an extensive family of lectins all characterized by
their affinity to bind b-galactosides.1,2 Galectins display a
multitude of biological functions in the extracellular and
intercellular compartments, mostly mediated by their multi-
meric or oligomerization nature.3,4 From the structural per-
spective, galectins are classified in three separate groups
according to their structure and domain organization: proto-
type galectins (-1, -2, -5, -7, -10, -11 -13, -14, and -15) which exist
as homodimers, chimera-type Gal-3 composed of a single
C-terminal domain bound to a short non-lectin N-terminal
linker, and tandem-repeat galectins (-4, -6, -8, -9, -12) with
two non-identical carbohydrate recognition domains (CRD)
linked together by a short peptide linker.5 Due to the bivalent
nature of tandem-repeat galectins and the oligomerization
tendency of prototype and chimera-types, galectins are able
to cross-link glycosylated receptors on the cell surface and
form supramolecular structures.6 Given their involvement in
a variety of pathologies, several galectins have been identified
as potential targets for drug discovery projects.7 Among galec-
tins, galectin-8 (Gal-8) is expressed across a wide number of
organs in the human body (including lung, kidney, spleen, liver
and heart).8 It has been suggested that its critical role for
mediating bacterial infection and autophagy is related, at
the molecular level, with its bivalent nature.9 Previous func-
tional and structural analysis have shown that the N- and
C-terminal domains of Gal-8 display different carbohydrate
specificity.10,11 Indeed, the N-terminal CRD (Gal-8N) preferen-
tially binds sulfated and sialylated saccharides, whereas the
C-terminal domain (Gal-8C), mostly recognizes polylactosa-
mine, histo-blood group antigen-like structures and binds to
the autophagic receptor NDP52 in the opposite side of the
carbohydrate-binding site.9,12–14 Noteworthy, glycan arrays
showed that the heterodimer, full-length Gal-8 (Gal-8FL), binds
a broader scope of structures than their isolated CRDs.15
Altogether these results strongly suggest the importance of
analysing the whole protein structure when studying the bio-
logical functions of Gal-8.16 Despite this, its structural analysis
has been limited to mutant forms in which the peptide linker
between both domains was mostly eliminated and replaced
with a histidine-methionine spacer.9,17 Herein, we report a
comprehensive structural analysis of the binding of Gal-8FL
to its natural ligands using a synergistic combination of NMR,
ITC experiments and molecular dynamics simulations. Our
results show that both CRDs of Gal-8FL bind minimal epitopes
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such as N-acetyllactosamine (LacNAc, 1) or Galb1-3GalNAc (2)
in a similar manner. In contrast, they show exquisite and
opposing specificity to bind either Neu5Ac- or Fuc-containing
ligands, such as 3 and 5–6, respectively. Moreover, the addition
of ligands which are specific for one of the CRDs did not
provide any effect at the alternative CRD. Thus, these results
experimentally demonstrate, for the first time, that both Gal-
8FL CRDs behave independently in terms of binding affinity
and specificity and, therefore, they may target different entities
simultaneously to promote clustering through the formation of
large supramolecular entities.
Results and discussion
Macroscopic methods, such as glycan arrays, fluorescence
anisotropy and frontal affinity chromatography have been pre-
viously employed to deduce the different binding specificities
of the two separate Gal-8 CRDs, highlighting the potential
of Gal-8FL to trigger clustering effects in glycan arrays.11,15
However, a detailed structural and chemical analysis of the
corresponding binding processes involving complex ligands
for Gal-8FL remains absent. Thus, the interaction between
the full-length protein and a repertoire of b-galactose-
containing saccharides was systematically analyzed to provide
a solid framework to understand the recognition process.
Gal-8FL and its two isolated CRDs were employed as lectins
and a variety of chemical entities (1–6) displaying diverse
epitopes and binding affinities were used as ligands (Fig. 1).
In particular, blood group antigens 5 and 6 were selected as
preferred ligands of Gal-8C, and their minimal epitopes 4 and 1
were analyzed for comparison. In contrast, ligand 2 and its
sialylated counterpart 3 were picked out as higher selective
Gal-8N ligands, due to the preference of the N-terminal CRD for
Galb1–3GalNAc vs. LacNAc.15
Isothermal titration calorimetry
ITC experiments were carried out to determine the binding
constants and thermodynamic profiles of the interaction
between Gal-8 and ligands 1–6 (Table 1).18 All experiments were
performed for Gal-8FL and the single N- and C-CRDs.
The affinities are in the low micromolar range, with LacNAc
(1) and Galb1–3GalNAc (2) being the exceptions. The affinity
of LacNAc (1) for both CRDs was very similar and remained
almost unaltered in the full-length form (DG = 4.22 
0.01 kcal mol1). Galb1–3GalNAc 2 showed similar affinities
for Gal-8N, Gal-8C and Gal8-FL (DG = 4.96  0.06 kcal mol1).
In contrast, the Galili trisaccharide (4), bearing an extra galac-
tose a1–3-linked to type II LacNAc, binds significantly stronger
(ca. 1 kcal mol1) to Gal-8C and Gal-8FL, with the affinity
towards Gal-8N remaining somewhat identical to that of Lac-
NAc (DDG = 0.2 kcal mol1). Interestingly, the introduction of
the sialyl moiety present in 3 resulted in a much increased
affinity (ca. 3 kcal mol1) for Gal-8N in comparison with its
unsialylated analog 2, whereas it prevented the binding to Gal-
8C. Contrarily, histo-blood group antigen B type II (5), with an
additional a1–2Fuc linked to Galili trisaccharide, displayed a
striking rise in affinity (41 kcal mol1) towards Gal-8C. Similar
results were obtained with HBGA A type II (6). Interestingly, no
interaction was shown for either of the blood group antigens to
Gal-8N. Of note, 3, 5 and 6, which are highly specific for Gal-8N
or Gal-8C, bind to Gal-8FL with similar affinities to those
measured for its corresponding individual domains, thus
reflecting the specific binding to just one single CRD. In fact,
almost identical thermodynamic signatures were obtained for
the binding between the 3-sialyl-Galb1-3GalNAc 3 or the BGA A
type II 6 and glycan-pre-loaded Gal-8FL species using 6 or 3,
respectively (Fig. 2 and Table 1). These results confirm the high
specificity of both N- and C-CRDs of Gal-8FL and suggest that
the two binding sites in the full-length protein do not show any
cooperativity.
NMR and molecular recognition
The high flexibility and instability to protease activity of the
full-length protein has prevented crystallization studies of
Gal-8FL so far.19 In fact, only the structural details of truncated
Gal-8FL forms, lacking the peptide linker between both
domains, have been reported.9,17 Although these mutants
resulted active and bind to b-galactosides, the interplay
between the binding to both subdomains was not examined.
Thus, in order to investigate the binding features of Gal8-FL
and to provide insights into the possible cooperativity between
the two domains, the molecular recognition event was analyzed
by using NMR experiments assisted by MD simulations.20
Particularly, the interaction of Gal-8FL with its high-affinity
ligands 3 and 6, together with LacNAc 1, the canonical ligand
for galectins, was analyzed by ligand-based and protein-based
NMR experiments. For 1, the simple analysis of broadening
effects of the sugar signals in the 1H-NMR spectrum in the
presence of the protein, coupled with 1H-STD-NMR experi-
ments, was sufficient to determine the ligand binding
epitope.21 In fact, substantial signal broadening was observed
for H3, H4 and H5 of the b-galactose ring. In a similar fashion,
signals for H3, H4 and H5 showed up in the 1H-STD-NMR
spectrum, although in this case higher temperatures were
Fig. 1 Schematic representation of the oligosaccharides whose inter-
action with Gal-8FL is described herein.
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required to increase the on–off exchange and in turn, to
enhance the intensity of STD signals (Fig. 3).22
These results were in complete agreement with the canoni-
cal binding mode shared for all galectins towards Lac/LacNAc
moieties, and more specifically with the X-ray crystallographic
data described for the complexes between Gal-8N and Gal-8FL
with lactose (pdb entries 3AP412 and 3VKL,17 respectively),
where the b-galactose unit, on the top of a Trp residue, estab-
lishes the main interactions with the lectin.23 Similar results
were obtained for 3, where both signal broadening (H4 and H6)
and STD signals (H2, H3, H4 and H5) were detected for the
central b-galactose (Fig. 3). Additionally, STD intensities were
observed for H4 and H6 of the b-GalNAc moiety as well as for
H3s of aNeu5Ac, showing their close proximity to the protein
surface. Indeed, weak STD signals were detected for H7–H9 of
Neu5Ac suggesting that only the exo–syn conformation of
Neu5Aca2–3Galb linkage was populated in the bound state.
As described for 1 and 3, the histo-blood group antigen 6
showed STD signals for the central b-Gal (H4, H5 and H6)
and for aGalNAc (H1 and H2). In contrast, no STD signals were
detected for the Fuc moiety (Fig. 3). Thus, the results obtained
so far allow describing the binding of these saccharides to Gal8-
FL as a simple bimolecular process, where b-galactosides 1, 3
and 6 interact with the CRDs of the protein following a lactose-
type binding mode.
Thus, in light of our NMR experimental data, initial 3D
models of the interaction of 3 and 6 with the individual Gal-8
CRDs were built. The ligands were docked in the binding site of
the protein by pair-fitting to lactose (crystal structures: PDB ID
3AP4 for Gal-8N and PDB IDs 3OJB and 3VKL for Gal-8C) and
subjected to molecular dynamics (MD) simulations (Fig. 3D).
The binding mode described above was also supported by
2D-trROESY experiments.25 Fittingly, for the complexes formed
between Gal-8FL and ligands 3 and 6, the chemical exchange
process between the free and bound sugars was under the slow-
exchange regime in the chemical shift time scale. Thus, 2D-
trROESY experiments resulted ideal to reveal the chemical
shifts of the protons of bound 3 and 6, allowing to guess their
chemical environment in the bound state. For ligand 3, a
striking up-field shift for H4 of the b-galactose in the bound-
state was detected. This fact is in full agreement with the
binding mode described above, where the b-galactose residue
lies on the top of W86. Moreover, H1 of GalNAc and H3s of
Neu5Ac also showed important chemical shift perturbations,
strongly supporting their proximity to the lectin in the bound
state. Interestingly, H3ax and H3eq of Neu5Ac showed opposite
chemical shift perturbation, nicely demonstrating their precise
and disparate chemical environment in the bound state. For
ligand 6 (A type II), H4, H5 and H6 of the central b-galactose
were the most up-field shifted in the presence of Gal-8FL, while
smaller changes were detected for other protons of the mole-
cule (Fig. 4). Interestingly, tr-ROESY experiments of ligands 3
and 6, employing either Gal-8C or Gal-8N isolated domains,
respectively, offered almost identical results (see ESI†), suggest-
ing that the binding kinetics of these high-affinity ligands
remained domain-independent in Gal-8FL.
Additional NMR experiments were performed from the point
of view of the protein to obtain complementary structural
Table 1 KD and thermodynamics parameters for the interactions of ligands 1–6 with Gal-8FL, Gal-8 N and Gal-8C, as determined by ITC. Average values
and standard deviations are indicated. The thermodynamic parameters for the binding of ligands 3 and 6 to Gal-8FL glycan pre-loaded species (runs in
which one CRD of Gal-8FL was saturated with its high-affinity ligand, 3 and 6 for the N- and C-CRD, respectively, and the interaction of the opposite CRD
with 6 and 3, respectively, was measured) are indicated in parenthesis. The low binding affinity of Gal-8C, Gal-8N and Gal-8FL towards LacNAc, Galb1–
3GalNAc and Galili prevented the accurate analysis of the data. Thus, N = 1 or N = 2 were employed as fixed values. DH and TDS contributions were not
estimated for these ligands24
LacNAc (1) Galb1–3GalNAc(2)
Neu5Aca2–3Galb1–
3GalNAc(3) Galili (4) B type II (5) A type II (6)
Gal8-FL KD (mM) 804  2 229  24 4.3  0.4
(3.0  0.2)
165  4/68  2 36.7  0.6 12  1
(17  1)




6.05  0.01 6.71  0.05
(6.50  0.04)
DH (kcal mol1) — — 13.5  0.1
(14.1  0.1)
— 10.9  0.2 11.9  0.2
(10.7  0.4)
TDS (kcal mol1) — — 6.2  0.2
(6.6  0.2)
— 4.8  0.2 5.1  0.1
(4.20  0.01)
n 2 2 0.92  0.06
(0.77  0.08)
1/2 1.36  0.02 1.09  0.05
(1.07  0.02)
Gal-8N KD (mM) 621  43 186  5 2.2  0.1 444  34 — —
DG (kcal mol1) 4.38  0.04 5.08  0.01 7.72  0.04 4.57  0.04 — —
DH (kcal mol1) — — 13  1 — — —
TDS (kcal mol1) — — 5  1 — — —
n 1 1 0.90  0.09 1 — —
Gal-8C KD (mM) 844  135 348  216 — 115.5  0.5 18.4  0.1 13.45  0.05
DG (kcal mol1) 4.02  0.09 4.9  0.3 — 5.37  0.01 6.46  0.01 6.65  0.01
DH (kcal mol1) — — — — 10.7  0.1 11.2  0.1
TDS (kcal mol1) — — — — 4.3  0.1 4.6  0.1
n 1 1 — 1 1.26  0.03 1.13  0.01
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information of the complexes.26 Although Gal-8FL (30kDa) is a
medium-size protein, signal overlapping and broadening was
remarkably low at 308 K and 15N-HSQC experiments allowed
monitoring the chemical-shift perturbation (CSP) induced
upon ligand binding (Fig. 5).27 Indeed, the 15N-HSQC spectra
of Gal-8FL and their CRDs, Gal-8N and Gal-8C, were almost
completely superimposable (see ESI,† for additional details),
thus showing the similarities in the chemical environment and
dynamics of both CRDs in the isolated and full-length isoforms.
Upon systematic addition of 1 (from 0.25 to 60 equivalents), a
progressive CSP of the 1H–15N cross-peaks of the NH amides of
Gal-8FL was observed, a common trend for ligands in the fast
exchange regime. These results show that LacNAc 1 binds to
Gal-8FL in the high mM–mM affinity range, in agreement with
the KD (804 mM) determined by ITC experiments. Analysis of the
CSP showed that the most perturbed residues are those located
in protein regions comprising both the N- and C-CRD binding
sites, thus supporting the fact that LacNAc 1 binds indiscrimi-
nately to both CRDs of Gal-8FL. Among the N-CRD residues, the
largest changes were detected for residues in strands S4, S5 and
loop L5. Further CSP were observed for amino acids away from
the binding site, such as those on F5, L2 and the loop
connecting with the linker. Similarly, the most perturbed
residues of the C-CRD comprised those belonging to the bind-
ing site, more specifically in strands S3–S5 and loops L5 and
L9. A completely different behavior was observed for ligands 3
and 6.
Fig. 2 (A) Energetic profile of the binding of A type II (6) to the C-CRD of
Gal-8FL (left) compared to the binding of A type II (6) to the C-CRD in the
presence of 3-sialyl-Galb1–3GalNAc (3) in the N-CRD of Gal-8FL (right).
(B) Energetic profile of the binding of 3-sialyl-Galb1–3GalNAc (3) to the N-
CRD of Gal-8FL (left) compared to the binding of 3-sialyl-Galb1–3GalNAc
(3) to the N-CRD in the presence of A type II (6) in the C-CRD of Gal-8FL.
Fig. 3 (A and B) 1H-STD-NMR spectra of ligands 3 and 6, respectively.
First spectrum: reference spectrum with annotation for those signals
showing STD intensity; second spectrum: STD spectrum with irradiation
of the protein on the aliphatic region; third spectrum: STD spectrum with
irradiation of the protein on the aromatic region. (C) Epitope mapping for
ligands 1, 3 and 6 determined by 1H-STD NMR experiments. (D) 3D models
for Gal-8N/3 and Gal-8C/6 complexes.
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In both cases, 10 equivalents of ligand or less were sufficient
to saturate the protein and broadening of signals was clearly
noticeable at intermediate ligand amounts (see ESI,† Fig. S10
and S11). This behavior clearly pointed to binding events in the
intermediate-slow exchange regime in the chemical shift time-
scale, in agreement with the higher binding affinity determined
by ITC experiments. Interestingly, the CSP observed for 3 was
definitely limited to N-CRD residues. This observation clearly
supports the exclusive binding of 3 to the N-CRD, without
altering other protein regions. In particular, amino acids in
strands S4–S6 and L5 loop, certainly involved in the recognition
of the b-galactose residue, showed clear CSP. Additionally,
residues in strands S3–S2 and loops L3 and L10 were signifi-
cantly perturbed, accounting for the accommodation of the
sialyl moiety. Indeed, the interaction of Gal8 N-term with the
glycans of the receptor binding domain of SARS CoV2 has been
shown to involve the sialyl epitope.28 These results, together
with the ligand-based NMR experiments29 described above,
highlight the direct participation of the Neu5Ac moiety in lectin
binding. Noteworthy, binding specificity completely switched
in the case of the histo-blood group antigen A type II 6. In this
case, the observed CSP were constrained to the C-CRD. As
described for 1, these CSP mainly involved amino acids in
strands S4–S5 and L5 loop. Further changes were also detected
for amino acids on L9, thus reflecting the presence of the
GalNAca epitope in 6 and its direct involvement in the recogni-
tion process.
MD Simulations of Gal-8FL in complex with ligands 1, 3 and 6
Atomistic models for full-length Gal-8 (Gal-8FL) in the apo and
bound states with ligands 1, 3, and 6 were constructed from the
X-ray structures of N- and C-terminal CRDs and an extended
peptide linker connecting both domains (see ESI†). Molecular
dynamics (MD) simulations were performed on these models to
yield an accumulated simulation time of 100 ms (see ESI†). In all
cases, unstructured folding of the flexible linker peptide was
observed. The most representative structure of these simula-
tions obtained after clustering analysis is depicted in Fig. 6.
This structure is highly conserved in the apo and bound states.
A systematic analysis of all the interactions between the peptide
linker and each CRD in apo Gal-8FL revealed the regions in
Fig. 4 Above: 2D-NMR ROESY spectrum of Gal-8FL : A type II (1 : 10). A
molecular model of the interaction, highlighting W249 and the b-Gal
residue was included. Below: comparison between the chemical shifts
obtained for the interaction of ligand 6 with Gal-8FL and Gal-8C.
Fig. 5 Top, CSP analysis for 1 (blue, 60 equivalents), 3 (green, 10 equiva-
lents) and 6 (red, 8 equivalents). Below, 3D models for the interaction of
Gal-8FL with 1, top-left; 3, top-right; 6, below. The most perturbed
residues are highlighted in dark (perturbated 42s) and light (perturbated
4s) colors.
Fig. 6 Model structure for Gal-8FL representing the most populated
cluster (67%) derived from MD simulations over an accumulated time of
100 ms. N-terminal and C-terminal CRDs are shown in blue and light
brown, respectively. The interdomain peptide linker is shown in green.
Ligands have been omitted for clarity.
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close contact with the linker (Fig. S12, ESI†). The N-terminal
CRD showed a larger number of highly dynamic interactions
with the peptide linker. However, and applying the methodol-
ogy previously reported by our group to analyse allosteric
networks,30 it was observed that the correlated motion of
binding residues quickly dissipated nearby each binding sites
without affecting the interdomain peptide (Fig. S14, ESI†). In
agreement with the measured CSP, the residues most fre-
quently involved in the calculated allosteric pathways (i.e. the
residues mostly affected by ligand binding) are concentrated in
the b-strands at the canonical binding sites of N- and C-CRDs of
Gal-8FL. Thus, the results support the independent behaviour
of both domains in Gal-8FL.
Simulations (consisting on many independent replicas) were
long enough to witness ligand unbinding events, which in turn
can be related to binding affinity (i.e. ligands with higher
affinity would remain bound longer throughout the simula-
tion). Thus, the relative binding affinities for 1, 3 and 6, both in
absence and presence of other ligands simultaneously bound to
the adjacent domain, were qualitatively estimated from the
fraction of the total simulation time in which each ligand is
bound in its canonical binding pose to the corresponding CRD
(Table 2). Such calculated ratios were compared to the experi-
mental dissociation constants (KD) measured by ITC. 3-Sialyl-
Galb1–3GalNAc 3 was experimentally determined to have the
smallest dissociation constant and the highest specificity
towards the N-terminal domain. Accordingly, this ligand stays
the longest bound to this domain. As a negative control, 3
escaped almost immediately when the binding sites for each
ligand were exchanged, attesting the observed regioselectivity.
Regarding the C-term CRD, 6 presents a higher experimental
affinity than LacNAc, which is reproduced by its consistently
larger residence time in the MD simulations. LacNAc is known
to bind both CRDs although with lower affinities, showing a
slightly higher preference towards the N-terminal domain.
The calculated residence times of this ligand bound to the
N- and C-terminal domains, also agree with the experimentally
observed trend.
Overall, a moderate correlation between experimental rela-
tive DG of binding and the calculated residence times was
found (Fig. 7), proving the ability of MD simulations to satis-
factorily estimate the relative binding affinities of the studied
ligands to Gal-8.
Conclusions
The two, N-terminal and C-terminal, domains of the full-length
human galectin-8, show an excellent and divergent specificity
to bind different saccharide antigens. Our results demonstrate
that the N-terminal domain nicely binds sialyl containing
saccharides, such as the 3-sialyl-Galb1–3GalNAc and does not
recognize the histo-blood group A or B saccharides. In contrast,
the C-terminal domain displays a complete opposite trend, as
demonstrated by detailed NMR investigations, both from the
ligand and lectin perspective, combined with ITC measure-
ments and complemented with MD simulations. The indepen-
dence of both CRDs in the full-length protein is fully sustained
by our results, especially when saturation at one binding site
(N-term or C-term) does not produce any effect at the alter-
native one (C-term or N-term). Thus, the two domains interact
with their ligands in an autonomous manner and may bind to
diverse molecular entities in a synchronised mode to foster
clustering and generating supramolecular assemblies.
Experimental
Ligands
Compounds 1 (LacNAc), 2 (Galb1–3GalNAc) and 3 (3-sialyl-
Galb1–3GalNAc) were purchased from Carbosynth (references
OA08244, OA01686 and, OS09250 respectively). Compounds 4
(Galili), 5 (histo blood B type II antigen) 6 (A type II) were
purchased from Elycityl (references GLY074-2, GLY038-2 and
GLY035-2).
Expression of unlabelled Gal8-FL, Gal-8N and Gal-8C
Each gene encoding either full-length isoform 1 (1–317 amino
acids) or the carbohydrate recognition domains (N-terminal
Table 2 MDs Residence Times. The residence time is defined as the
fraction of simulation time in which the ligand is bound in its canonical
binding pose before leaving the active site accumulated through 20 ms
(except for the negative control system, Gal-8 N-term:6-C-term:3, for
which the accumulated time is 5 ms)
Ligand MDs Residence time
N-terminal domain C-terminal domain N-term C-term
LacNAc (1) LacNAc (1) 40% 13%






A type II (6) 77% 25%
Negative control:
A type II (6) 3-Sialyl-Galb1-
3GalNAc (3)
32% 1%
Fig. 7 Representation of the percentage of bound residence time versus
the experimentally measured DDG. The domain for which the residence
time of the bound ligand is calculated is marked in bold.
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CRD, 1–155 amino acids and C-terminal CRD, 184–317) of
human Gal-8 were inserted into a pET21b expression vector.
Transformation of BL21 (D3) E. coli competent cells with the
expression vector was performed by heat shock method (42 1C
for 90 s, 5 minutes in ice). After being incubated overnight on
agar plates in the presence of ampicillin at 37 1C, one single
colony harbouring the expression construct was inoculated into
200 mL Luria Broth (LB) medium containing 100 mg mL1
ampicillin and it was cultured overnight at 37 1C with shaking.
A certain volume of the pre-culture was added to 2 L of new LB
medium with ampicillin In order to get an OD600 of 0.1. Cells
were grown at 37 1C until OD600 was between 0.6–1.2. Then,
protein expression was induced with 1 mM Isopropyl b-D-1-thio-
galactopyranoside (IPTG) and cell culture grow for another 3 h
at 37 1C. Afterwards, cells were harvested by centrifugation at
5500 rpm for 20 min. The obtained pellets were purified
following the protocols explained below.
Expression of 15N labelled Gal-8FL, Gal-8N and Gal-8C
Each gene encoding the carbohydrate recognition domains
(N-terminal CRD, 1-155 amino acids and C-terminal CRD,
184–317) of human Gal-8 were inserted into a pET21b expres-
sion vector. Transformation of BL21 (D3) E. coli competent cells
with the expression vector was performed by heat shock
method (42 1C for 90 s, 5 minutes in ice). After being incubated
overnight on agar plates in the presence of ampicillin at 37 1C,
one colony harbouring the expression construct was inoculated
into 3 mL Luria Broth (LB) me-dim containing 100 mg mL1
ampicillin and then, cultured with shaking for 6 h at 37 1C. The
culture was centrifuged for 5 minutes at 4400 rpm and the
subsequent pellet resuspended in 1 mL of M9 medium, con-
taining ampicillin. It was then transferred into a flask with
200 mL of the same ampicillin-containing M9 medium and
incubated overnight at 37 1C with shaking. In order to get an
OD600 of 0.1 a certain volume of the culture was added to 2 L
of new M9 labelled (15N-NH4Cl as nitrogen source) medium
with ampicillin. Cells were grown at 37 1C until OD600 was
between 0.6–1.2, induced with 1 mM Isopropyl b-D-1-thio-
galactopyranoside (IPTG) and then grown for another 3 h
at 37 1C. Finally, cells were harvested by centrifugation at
5500 rpm for 20 min. The obtained pellets were purified
following the protocols explained below in the Purification of
Gal-8FL and Gal-8N and Purification of Gal-8C sections.
Expression of 13C, 15N labelled Gal-8N
13C, 15N labelled Gal-8N was expressed and purified following
the protocol described in the Expression of 15N labelled Gal-
8FL, Gal-8N and Gal-8C section and Purification of Gal-8FL and
Gal-8N section, respectively, with the only variation being the
addition of 13C-glucose as carbon source as well as 15N-NH4Cl
as nitrogen source.
Purification of Gal-8FL and Gal-8N
The pellet obtained in the expression process was resuspended
in 10 mL of lysis buffer/g of pellet with the lysis buffer having
2 mM EDTA, 4 mM b-mercaptoethanol and 0.1% NaN3 in
phosphate-buffered saline (50 mM sodium phosphate, 150
mM NaCl, pH 7.4) and was then left in an ice bath for 30
minutes with shaking. The cell suspension was lysed by sonica-
tion in ice (60% amplitude, 12  20 s, with 59 seconds intervals
between each burst). The crude extract was clarified by ultra-
centrifugation at 35 000 rpm for 30 min at 4 1C. The soluble
fraction was loaded onto 5 mL a-lactose-agarose resin (Sigma–
Aldrich) previously equilibrated with lysis buffer. The column
loaded was washed with 120 mL of equilibration buffer and
then the lectin was eluted with 7 mL of elution buffer having
150 mM a-lactose and 1 mM DTT in phosphate-buffered saline
(50 mM sodium phosphate, 150 mM NaCl, pH 7.4). Full-length
hGal-8 and N-terminal CRD purity was checked by 4–12% SDS–
PAGE and by LC-MS. To eliminate the lactose from the protein
sample, a series of dialysis and washes with centrifuge filters
(Sartorius Vivaspin 6 5000 MWCO) using fresh buffer (PBS 1,
1 mM DTT and NaN3 0.1% pH 7.4) were performed. The
absence of lactose was checked by NMR. The addition of
the reducing agent in the buffer of hGal-8 is justified by the
presence of cysteine residues exposed to the solvent that could
cause the formation of non-specific dimers or aggregates
through inter-molecular disulphide bonds.
Purification of Gal-8C
The pellet obtained in the expression process was resuspended
in 10 mL of lysis buffer/g of pellet with the lysis buffer having
1 mM PMSF in phosphate-buffered saline (50 mM sodium
phosphate, 150 mM NaCl, pH 7.4) and was then left in an ice
bath for 30 minutes with shaking. The cell suspension was
lysed by sonication in ice (60% amplitude, 12  20 s, with
59 seconds intervals between each burst). Protein was purified
through a HisTrap Ni-NTA column (GE Healthcare) followed by
size exclusion chromatography on a Superdex 75 HiLoad 26/600
column (GE Healthcare).
NMR experiments
General information. 500 mL were used as total volume for all
NMR samples, using a precision NMR tube with 5 mm outer
diameter (New Era Enterprises, Vineland, USA). All pH mea-
surements of the buffers were performed with pH-meter Crison
Basic 20 (Crison Instruments SA, Barcelona, Spain) and
adjusted with the required amount of NaOH and HCl or NaOD
and DCl.
Backbone assignment of Gal-8FL
Backbone assignment of Gal-8FL was establish by minimum
chemical shift procedure, in which each resonance of the full-
length protein was linked to the least shifted signals of Gal-8N
and Gal-8C isolated domains. To this end, 15N Gal-8C backbone
assignment deposited in the Biological Magnetic Resonance
Data Bank (BMRB entry 25 453)31 was employed, whereas the
Gal-8N backbone assignment was kindly provided by Dr S. T. D.
Hsu. The unambiguous identification of 73% of the NH signals
of Gal-8N was accomplished by the acquisition and assignment
of standard 3D NMR experiments. 3D HNCACB, HN(CO)CACB,
HNCA, HN(CO)CA, HNCO and HN(CA)CO experiments were
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acquired using Bruker AVANCE 2 800 MHz spectrometer
equipped with cryoprobe and using a 560 mM sample of Gal-
8N in the presence of 150 mM lactose. The spectra
were processed with Bruker Topspin 3.5 and analysed via
CARANMR 1.9.1.
Saturation transfer difference (STD) NMR
STD experiments were acquired using Bruker AVANCE 2 800
MHz spectrometer equipped with cryoprobe. All samples were
prepared in deuterated phosphate-buffered saline (50 mM
sodium phosphate, 150 mM NaCl, pH 7.4) with 1 mM of
dithiothreitol-d10 (DTT-d10) and 0.1% NaN3. All experiments
were acquired at 308 K. In the case of high-affinity ligands 1 : 30
ratios of ligand : Gal-8 were used with the concentration of
unlabelled protein set at 30 and 40 mM for ligands 3 and 6,
respectively. Higher equivalents of ligand (ratio 1 : 100) were
used to amplify the STD effect for ligands in fast-exchange
regime. An in-house 1D-STD sequence using 901 PC9 pulses for
protein saturation and 100 ms T1rho protein filter was
employed for STD experiments. Acquisition was done with
4608 scans, 2 s of total saturation time and 3 s of relaxation
delay. The on- and off-resonance spectra were registered in an
interleaved mode with the same number of scans. On-
resonance saturation was set between 0.61 and 0.91 ppm for
the aliphatic region and in 6.99 ppm for the aromatic, while the
off-resonance saturation was set at 30 ppm. The STD NMR
spectra were obtained by subtracting the on-resonance spec-
trum from the off-resonance spectrum. The analysis of the
spectra was carried out using the proton signal with the
strongest STD effect as reference (100% of STD effect). On this
basis the relative STD intensities for the others protons of the
molecule were calculated.
2D-ROESY NMR experiments
ROESY experiments were acquired using Bruker AVANCE 2
800 MHz spectrometer equipped with cryoprobe. All samples
were prepared in deuterated phosphate-buffered saline (50 mM
sodium phosphate, 150 mM NaCl, pH 7.4) with 1 mM of
dithiothreitol-d10 (DTT-d10) and 0.1% NaN3. A protein concen-
tration of 100 mM was used with a protein : ligand ratio of
1 : 10 for ligand 3 and 1 : 8 for ligand 6. All experiments were
acquired at 298 K. An in-house ROESY sequence using a 100 ms
mixing time was used.
Chemical shift perturbation (CSP) analysis
15N-HSQC experiments were acquired using Bruker AVANCE
2 800 MHz spectrometer equipped with cryoprobe. Samples
containing 100 mM 15N labelled Gal-8 in 90% phosphate-
buffered saline (50 mM sodium phosphate, 150 mM NaCl, pH
7.4)/10% D2O with 1 mM of dithiothreitol (DTT) and 0.1% NaN3
were prepared. All experiments were acquired at 308 K. The
ligands were titrated in the protein samples (0.25–0.5–1–3–6–9–
12–15–20–25–30–40–60 equivalents for ligand 1, 0.5–1–1.5–2.5–
5–10 for ligand 3 and 0.25–0.5–0.75–1–1.5–2–5–8 for ligand 6) and
15N-HSQC experiments were acquired at each intermediate point.
An in-house TROSY sequence was used with 256 (T1)  1536 (T2)
complex data points in 15N and 1H dimensions, respectively.
The CSP data were analysed using CcpNmr Analysis software.
The CSP of the protein-backbone NH groups were calculated
using the formula: Dd (ppm) = [(DdH
2 + (0.14DdN)2)/2]1/2 and the
results were graphically plotted.
Isothermal titration calorimetry (ITC)
Isothermal titration calorimetry experiments were performed
using MicroCal PEAQ-ITC calorimeter. All experiments were
acquired at 298 K with every run being performed at least in
duplicate. Gal-8 and ligand samples (1–6) were prepared in
phosphate-buffered saline (50 mM sodium phosphate, 150 mM
NaCl, pH 7.4) with 1 mM TCEP as reducing agent. The concen-
tration of the protein solution was set at around 100 mM
and that of the sugar stock between 3–12 mM. During the
automated experiment, small amounts of the sugar solution
(1.20–2.40 mL) were titrated into a cell containing the protein
solution and the dispersed heat was detected. The association
constants and the thermodynamic parameters were obtained
from data fitting to a single-site (Gal-8, Gal-8C and Gal-8FL with
selective ligands) or 1 : 2 (Gal-8FL with non-selective ligands)
binding model. In the case of low-affinity ligands (LacNAc,
Galb1–3GalNAc and Galili) n values were fixed to n = 1 or n =
2 (for the interaction Gal-8FL/LacNAc and Gal-8FL/Galb1–3Gal-
NAc) for data fitting. Final data were shown in Table 1 as
average  standard deviation of two independent runs. When
the standard deviation calculated from two independent mea-
surements was lower than the precision given by the instru-
ment, the latter value was used to determine the accuracy of the
final displayed data. Examples of titration profiles for each
complex with data fitting to single-site binding model are
reported in the ESI.†
Model building
Full-length human galectin-8 was constructed from the crystal-
lographic coordinates of the N- (PDB code: 4BMB; residues
1–150) and C-terminal (PDB code: 3OJB; residues 184–317)
CRDs. The unresolved peptide linker (residues 151–183) was
built in an extended conformation using the tleap module of
Amber 18. The three fragments were manually assembled using
PyMol and the resulting full-length structure was refined
through MD simulations (see below).
Molecular dynamics
Molecular dynamics (MD) simulations were run with the Amber
18 suite,32,33 using the ff14SB34 and GLYCAM 06j-135 force fields
for the proteins and carbohydrate ligands, respectively. Binding
histidine residues (H65 and H229) were modelled in their Nd1–
H tautomeric state (reside name HID in Amber). Initial struc-
tures were neutralized with either Na+ or Cl ions and set at the
centre of a cubic TIP3P water36 box with a buffering distance
between solute and box of 10 Å. For each system, we followed
a two-stage geometry optimization approach: the first stage
minimizes only the positions of solvent molecules and ions,
and the second stage is an unrestrained minimization of all the
atoms in the simulation cell. The systems were then heated by
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incrementing the temperature from 0 to 300 K under a constant
pressure of 1 atm and periodic boundary conditions. Harmonic
restraints of 10 kcal mol1 were applied to the solute, under
the Andersen temperature coupling scheme.37,38 The time step
was kept at 1 fs during the heating stages, allowing potential
inhomogeneities to self-adjust. Water molecules were treated
with the SHAKE algorithm39 such that the angle between the
hydrogen atoms is kept fixed through the simulations. Long-
range electrostatic effects were modelled using the particle
mesh Ewald method.40 An 8 Å cut-off was applied to Lennard-
Jones interactions. Each system was equilibrated for 2 ns with a
2 fs time step at a constant volume and temperature of 300 K.
Ten independent production trajectories were then run for
additional 2.0 ms under the same simulation conditions,
leading to accumulated simulation times of 20.0 ms for each
system (hGal-8, hGal-8_N-term:LacNAc_C-term:LacNAc, hGal-
8_N-term:3-sialyl-Galb1–3GalNAc, hGal-8_C-term:A typeII, and
hGal-8_N-term:3-sialyl-Galb1–3GalNAc_C-term:AtypeII). For the
complex used as a negative control (hGal-8-_N-term:AtypeII_C-
term:3-sialyl-Galb1–3GalNAc), five independent 1.0 ms produc-
tion trajectories were run. Additionally, five 200 ns production
trajectories were run for the isolated N- and C-terminal
domains in complex with 3-sialyl-Galb1–3GalNAc and A
type II respectively.
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Jiménez-Oses (for the MD part), Ana Ardá, and Jesús Jiménez-
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